ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $553M invested in Intra-Cellular Therapies Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 26
Holders
131
Holding in Top 10
–
Calls
$10.7M
Puts
$6.7M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$4.97M | |
| 3 | +$3.82M | |
| 4 |
SC
Samlyn Capital
New York
|
+$3.69M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.21M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$14.7M | |
| 3 | -$14.5M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$9.8M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$8.66M |